EDWARDS LIFESCIENCES CORP (EWL.DE) Fundamental Analysis & Valuation

FRA:EWL • US28176E1082

72.68 EUR
-1.23 (-1.66%)
Last: Mar 3, 2026, 07:00 PM

This EWL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to EWL. EWL was compared to 63 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making EWL a very profitable company, without any liquidiy or solvency issues. While showing a medium growth rate, EWL is valued expensive at the moment. These ratings could make EWL a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

7

1. EWL.DE Profitability Analysis

1.1 Basic Checks

  • EWL had positive earnings in the past year.
  • EWL had a positive operating cash flow in the past year.
  • In the past 5 years EWL has always been profitable.
  • EWL had a positive operating cash flow in 4 of the past 5 years.
EWL.DE Yearly Net Income VS EBIT VS OCF VS FCFEWL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

  • EWL has a better Return On Assets (10.31%) than 90.48% of its industry peers.
  • EWL has a better Return On Equity (13.40%) than 76.19% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 12.09%, EWL belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROIC 12.09%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EWL.DE Yearly ROA, ROE, ROICEWL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • Looking at the Profit Margin, with a value of 23.25%, EWL belongs to the top of the industry, outperforming 92.06% of the companies in the same industry.
  • EWL's Profit Margin has been stable in the last couple of years.
  • EWL has a better Operating Margin (27.73%) than 96.83% of its industry peers.
  • EWL's Operating Margin has declined in the last couple of years.
  • With an excellent Gross Margin value of 78.19%, EWL belongs to the best of the industry, outperforming 92.06% of the companies in the same industry.
  • In the last couple of years the Gross Margin of EWL has remained more or less at the same level.
Industry RankSector Rank
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
OM growth 3Y-8.34%
OM growth 5Y-1.77%
PM growth 3Y-19.64%
PM growth 5Y-1.18%
GM growth 3Y-2.35%
GM growth 5Y0.69%
EWL.DE Yearly Profit, Operating, Gross MarginsEWL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

9

2. EWL.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EWL is still creating some value.
  • There is no outstanding debt for EWL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EWL.DE Yearly Shares OutstandingEWL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
EWL.DE Yearly Total Debt VS Total AssetsEWL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 12.35 indicates that EWL is not in any danger for bankruptcy at the moment.
  • EWL's Altman-Z score of 12.35 is amongst the best of the industry. EWL outperforms 93.65% of its industry peers.
  • EWL has a debt to FCF ratio of 0.75. This is a very positive value and a sign of high solvency as it would only need 0.75 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.75, EWL belongs to the top of the industry, outperforming 93.65% of the companies in the same industry.
  • EWL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of EWL (0.06) is better than 87.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Altman-Z 12.35
ROIC/WACC1.21
WACC9.97%
EWL.DE Yearly LT Debt VS Equity VS FCFEWL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

  • EWL has a Current Ratio of 4.00. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 4.00, EWL belongs to the best of the industry, outperforming 92.06% of the companies in the same industry.
  • A Quick Ratio of 3.29 indicates that EWL has no problem at all paying its short term obligations.
  • The Quick ratio of EWL (3.29) is better than 92.06% of its industry peers.
Industry RankSector Rank
Current Ratio 4
Quick Ratio 3.29
EWL.DE Yearly Current Assets VS Current LiabilitesEWL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. EWL.DE Growth Analysis

3.1 Past

  • The earnings per share for EWL have decreased by -2.29% in the last year.
  • EWL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.67% yearly.
  • The Revenue has grown by 10.86% in the past year. This is quite good.
  • EWL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.70% yearly.
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
Revenue 1Y (TTM)10.86%
Revenue growth 3Y10.77%
Revenue growth 5Y6.7%
Sales Q2Q%13.26%

3.2 Future

  • EWL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.79% yearly.
  • The Revenue is expected to grow by 9.72% on average over the next years. This is quite good.
EPS Next Y16.14%
EPS Next 2Y13.34%
EPS Next 3Y13.01%
EPS Next 5Y12.79%
Revenue Next Year10.47%
Revenue Next 2Y10.14%
Revenue Next 3Y10.12%
Revenue Next 5Y9.72%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EWL.DE Yearly Revenue VS EstimatesEWL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
EWL.DE Yearly EPS VS EstimatesEWL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

2

4. EWL.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 32.89, which means the current valuation is very expensive for EWL.
  • The rest of the industry has a similar Price/Earnings ratio as EWL.
  • Compared to an average S&P500 Price/Earnings ratio of 26.83, EWL is valued a bit more expensive.
  • EWL is valuated quite expensively with a Price/Forward Earnings ratio of 28.37.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of EWL indicates a slightly more expensive valuation: EWL is more expensive than 66.67% of the companies listed in the same industry.
  • EWL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.95.
Industry RankSector Rank
PE 32.89
Fwd PE 28.37
EWL.DE Price Earnings VS Forward Price EarningsEWL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EWL is valued a bit more expensive than the industry average as 65.08% of the companies are valued more cheaply.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as EWL.
Industry RankSector Rank
P/FCF 61.22
EV/EBITDA 24.91
EWL.DE Per share dataEWL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EWL does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of EWL may justify a higher PE ratio.
  • A more expensive valuation may be justified as EWL's earnings are expected to grow with 13.01% in the coming years.
PEG (NY)2.04
PEG (5Y)4.93
EPS Next 2Y13.34%
EPS Next 3Y13.01%

0

5. EWL.DE Dividend Analysis

5.1 Amount

  • No dividends for EWL!.
Industry RankSector Rank
Dividend Yield 0%

EWL.DE Fundamentals: All Metrics, Ratios and Statistics

EDWARDS LIFESCIENCES CORP

FRA:EWL (3/3/2026, 7:00:00 PM)

72.68

-1.23 (-1.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)04-21
Inst Owners89.94%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap42.18B
Revenue(TTM)6.07B
Net Income(TTM)1.37B
Analysts79.53
Price Target81.61 (12.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)2
Avg Revenue beat(12)-2.12%
Revenue beat(16)2
Avg Revenue beat(16)-2.48%
PT rev (1m)-3.53%
PT rev (3m)0.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.25%
EPS NY rev (1m)0.43%
EPS NY rev (3m)1.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.31%
Revenue NY rev (1m)0.67%
Revenue NY rev (3m)0.9%
Valuation
Industry RankSector Rank
PE 32.89
Fwd PE 28.37
P/S 8.32
P/FCF 61.22
P/OCF 48.14
P/B 4.8
P/tB 6.7
EV/EBITDA 24.91
EPS(TTM)2.21
EY3.04%
EPS(NY)2.56
Fwd EY3.52%
FCF(TTM)1.19
FCFY1.63%
OCF(TTM)1.51
OCFY2.08%
SpS8.74
BVpS15.15
TBVpS10.85
PEG (NY)2.04
PEG (5Y)4.93
Graham Number27.45
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROCE 13.97%
ROIC 12.09%
ROICexc 18.01%
ROICexgc 28.58%
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
FCFM 13.59%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.34%
OM growth 5Y-1.77%
PM growth 3Y-19.64%
PM growth 5Y-1.18%
GM growth 3Y-2.35%
GM growth 5Y0.69%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Debt/EBITDA 0.33
Cap/Depr 138.79%
Cap/Sales 3.69%
Interest Coverage 250
Cash Conversion 56.86%
Profit Quality 58.45%
Current Ratio 4
Quick Ratio 3.29
Altman-Z 12.35
F-Score5
WACC9.97%
ROIC/WACC1.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
EPS Next Y16.14%
EPS Next 2Y13.34%
EPS Next 3Y13.01%
EPS Next 5Y12.79%
Revenue 1Y (TTM)10.86%
Revenue growth 3Y10.77%
Revenue growth 5Y6.7%
Sales Q2Q%13.26%
Revenue Next Year10.47%
Revenue Next 2Y10.14%
Revenue Next 3Y10.12%
Revenue Next 5Y9.72%
EBIT growth 1Y4.68%
EBIT growth 3Y1.54%
EBIT growth 5Y4.82%
EBIT Next Year25.88%
EBIT Next 3Y16.1%
EBIT Next 5Y14.72%
FCF growth 1Y67.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.09%
OCF growth 3YN/A
OCF growth 5YN/A

EDWARDS LIFESCIENCES CORP / EWL.DE FAQ

Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?

ChartMill assigns a fundamental rating of 6 / 10 to EWL.DE.


What is the valuation status of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.


What is the profitability of EWL stock?

EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 7 / 10.


What are the PE and PB ratios of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 32.89 and the Price/Book (PB) ratio is 4.8.